BioMed Alliance and the EU Health Coalition have published a joint statement calling on EU institutions and Member States to take action to reverse Europe’s declining position in global clinical research and build an ecosystem that better serves patients and innovation.
The statement highlights the challenges facing clinical research in Europe and sets out key priorities for action, including simplifying regulatory processes, strengthening cross-border collaboration, supporting both commercial and non-commercial research, putting patients at the centre, investing in research capacity and data, and improving the implementation of reforms.
With the proposed European Biotech Act and the European Health Data Space (EHDS) offering important opportunities to address existing barriers, the Coalition urges decision-makers to build on these initiatives and deliver concrete improvements for patients, researchers and innovators across Europe.
Read the full statement here: How can Europe build a clinical trials ecosystem that delivers for patients and innovation?
